Leidos is trading 4.1% higher at $118.20 on October 8, 2026, with no clear catalyst identified.

  • JPMorgan downgraded Leidos to Neutral from Overweight and cut its price target to $142 from $160; the negative action does not explain the gain.
  • Broader markets and defense stocks were lower, so the move does not appear to track the reported market trend.